US$ 28.29
igf-1 lr3 laboratory inquiry PEPTIDE 1MG/10MG VIAL – UMBRELLA Labs IGF-1 LR3 VIAL - High
Description
10.1186/1476-4598-6-66 23 BenguiguiM.WeitzI

doi: 10.1007/s13167-020-00217-y

In clinical studies of 71 subjects with Primary IGFD treated for a mean duration of 3.9 years and representing 274 subject-years, no subjects withdrew from any clinical study because of adverse reactions

Some see results in a few weeks, while others maintain therapy for long-term health and performance optimization

It can be used as an effective anti-cancer drug on its own or in combination with other drugs to inhibit tumor cell growth by influencing different signaling pathways and molecular targets involved in the development of multiple cancers (Giordano and Tommonaro, 2019)
